1. Home
  2. |Insights
  3. |8th Annual Renewable Energy Finance Forum-West

8th Annual Renewable Energy Finance Forum-West

Event | 11.05.15 - 11.06.15, 12:00 AM UTC - 12:00 AM UTC

Address

Four Seasons Hotel
757 Market Street, San Francisco, CA

REFF-West is the premier West Coast renewable energy finance event, uniting senior financiers, investors, and renewable energy executives from across the country since 2008.

With a focus on renewable energy development in the Western U.S., REFF-West will highlight financing trends in renewable power, energy storage, system integration, and transportation; review important developments in Western power market expansion and in the role of the emerging corporate customer market segment; and discuss renewable energy’s role in smarter resource use and response to the Western water crisis. Join them to find out what these developments mean for the industry’s cost of capital and discover growing opportunities in renewable energy on the West Coast. The conference also offers unparalleled networking opportunities, allowing you to meet senior representatives from both the energy and financial sectors.

REFF-West is built on the success of REFF-Wall Street, the nation’s largest annual event for renewable energy finance that takes place each June and attracts over 600 participants. Both REFF-West and REFF-Wall Street are co-organized by the American Council On Renewable Energy (ACORE) and Euromoney Seminars.

Nancy Saracino is the Moderator of the topic: "Think Tank: Western Power Market Expansion."

For more information, please visit these areas: Litigation and Trial

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.